86 related articles for article (PubMed ID: 8020831)
1. Elevated prothrombin fragment 1 + 2 (F1 + 2) plasma levels may provide evidence of hypercoagulable states in gynecologic emergencies.
Anand A
Gynecol Oncol; 1994 Jul; 54(1):101. PubMed ID: 8020831
[No Abstract] [Full Text] [Related]
2. [Evaluation of hypercoagulable state in patients with malignancies by using prothrombin fragment F1 + 2].
Nakagawa K; Tsuji H; Yamada K; Yamada Y; Masuda H; Yamagami M; Yoneda M; Takada O; Sawada S; Kitani T
Rinsho Ketsueki; 1992 Nov; 33(11):1666-72. PubMed ID: 1469781
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of an enzyme-linked immunosorbent assay for the determination of prothrombin fragment F1.2 (Dade Prothrombin Fragment F1.2 ELISA: Baxter Diagnostics Inc., U.S.A.) using micro-titer plate].
Suzuki T; Amano K; Kuroso K; Fukutake K; Fujimaki M
Rinsho Byori; 1993 Feb; 41(2):215-9. PubMed ID: 8361024
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of plasma prothrombin fragment 1+2 in healthy donors and thrombotic diseases].
Kawai Y; Shiomi T; Ono H; Katagiri H; Uchida R; Sugisaki N; Watanabe K
Rinsho Byori; 1994 Jan; 42(1):57-62. PubMed ID: 8107284
[TBL] [Abstract][Full Text] [Related]
5. [Prothrombin (factor II) and prothrombin fragment 1+2 (F1+2)].
Maruyama I
Nihon Rinsho; 2004 Dec; 62 Suppl 12():623-5. PubMed ID: 15658406
[No Abstract] [Full Text] [Related]
6. Serum des-R prothrombin activation peptide fragment 2: a novel prognostic marker for disseminated intravascular coagulation.
Chung S; Kim JE; Kim HK; Yeon EH; Shin YS; Kim CW
Thromb Res; 2013 Jun; 131(6):547-53. PubMed ID: 23664563
[TBL] [Abstract][Full Text] [Related]
7. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
[TBL] [Abstract][Full Text] [Related]
8. Prothrombin fragment F1+2 and thrombin-antithrombin III complex (TAT) plasma levels in patients with gynecological cancer.
Gadducci A; Marrai R; Baicchi U; Gagetti O; Facchini V; Genazzani AR
Gynecol Oncol; 1996 May; 61(2):215-7. PubMed ID: 8626135
[TBL] [Abstract][Full Text] [Related]
9. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
[TBL] [Abstract][Full Text] [Related]
10. Association between prothrombin activation fragment (F1.2), cerebral ischemia (S-100beta) and international normalized ratio (INR) in patients with ventricular assisted devices.
Joshi A; Magder LS; Kon Z; Kallam S; Kwon M; Sangrampurkar R; Pierson R; Poston R
Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):323-7. PubMed ID: 17669856
[TBL] [Abstract][Full Text] [Related]
11. Antithrombin deficiency in special clinical syndromes--Part II: panel discussion #2.
Sacher R
Semin Hematol; 1995 Oct; 32(4 Suppl 2):67-71. PubMed ID: 8821213
[No Abstract] [Full Text] [Related]
12. Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency.
Zöller B; Holm J; Svensson P; Dahlbäck B
Thromb Haemost; 1996 Feb; 75(2):270-4. PubMed ID: 8815575
[TBL] [Abstract][Full Text] [Related]
13. Concentration of prothrombin fragment 1 + 2 (f1 + 2) in patients with liver cirrhosis and chronic hepatitis C infection.
Fota-Markowska H; Modrzewska R; Krzowska-Firych J; Lis-Tønder J; Borowicz I
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):4-7. PubMed ID: 16146040
[TBL] [Abstract][Full Text] [Related]
14. Determination of prothrombin activation fragments in young patients with inflammatory bowel disease.
Smith CJ; Haire WD; Kaufman SS; Mack DR
Am J Gastroenterol; 1996 Jun; 91(6):1221-5. PubMed ID: 8651175
[TBL] [Abstract][Full Text] [Related]
15. Influence of hormone replacement therapy (17 beta-OH estradiol and medroxyprogesterone acetate) on plasma concentration of prothrombin fragment F1+2 and thrombin-antithrombin III complex in postmenopausal woman.
Ciepłluch R; Czestochowska E
Acta Haematol Pol; 1996; 27(1):21-5. PubMed ID: 8629439
[TBL] [Abstract][Full Text] [Related]
16. [Malignant tumors and disseminated intravascular coagulation].
Katoh H; Ohsato K
Rinsho Byori; 1985 Jun; Spec No 63():164-70. PubMed ID: 3900484
[No Abstract] [Full Text] [Related]
17. [Prothrombin fragment F1 + 2].
Kohlhaussen T
Dtsch Med Wochenschr; 1993 Oct; 118(41):1504. PubMed ID: 8404515
[No Abstract] [Full Text] [Related]
18. Levels of prothrombin fragment F1+2 in patients with hyperhomocysteinemia and a history of venous thromboembolism.
Kyrle PA; Stümpflen A; Hirschl M; Bialonczyk C; Herkner K; Speiser W; Weltermann A; Kaider A; Pabinger I; Lechner K; Eichinger S
Thromb Haemost; 1997 Nov; 78(5):1327-31. PubMed ID: 9408013
[TBL] [Abstract][Full Text] [Related]
19. [Metabolism and distribution of I-131 fibrinogen in cancer patients with disseminated intravascular coagulation syndrome].
D'addabbo ; Macarini N; Damato V; Fanfani G; Fratello A; Ciavarella N
J Radiol Electrol Med Nucl; 1975; 56 suppl 2():658-60. PubMed ID: 1232374
[No Abstract] [Full Text] [Related]
20. [Intravascular coagulation of blood in patients with malignant neoplasms].
Nadiradze ISh
Khirurgiia (Mosk); 1983 Sep; (9):131-4. PubMed ID: 6355630
[No Abstract] [Full Text] [Related]
[Next] [New Search]
